Detalhe da pesquisa
1.
Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cochrane Database Syst Rev;
2: CD012857, 2022 Feb 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35201607
2.
Are investigators' access to trial data and rights to publish restricted and are potential trial participants informed about this? A comparison of trial protocols and informed consent materials.
BMC Med Ethics;
22(1): 115, 2021 08 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34454496
3.
General health checks in adults for reducing morbidity and mortality from disease.
Cochrane Database Syst Rev;
1: CD009009, 2019 01 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30699470
4.
Screening for reducing morbidity and mortality in malignant melanoma.
Cochrane Database Syst Rev;
6: CD012352, 2019 06 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31157404
5.
Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Ann Intern Med;
166(5): 313-323, 2017 Mar 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28114661
6.
Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.
CMAJ;
189(5): E194-E203, 2017 Feb 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28246265
7.
The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.
Evid Based Med;
22(4): 143-147, 2017 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28705922
8.
Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis.
PLoS Med;
13(8): e1002101, 2016 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27529343
9.
Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease.
Cochrane Database Syst Rev;
9: CD007851, 2016 Sep 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27644166
10.
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Ann Intern Med;
162(11): 777-84, 2015 Jun 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26030634
11.
Increasing value and reducing waste: addressing inaccessible research.
Lancet;
383(9913): 257-66, 2014 Jan 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24411650
12.
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis.
Cochrane Database Syst Rev;
(8): CD001399, 2015 Aug 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26298311
13.
Screening with urinary dipsticks for reducing morbidity and mortality.
Cochrane Database Syst Rev;
1: CD010007, 2015 Jan 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25626128
14.
SPIRIT 2013 Statement: defining standard protocol items for clinical trials.
Rev Panam Salud Publica;
38(6): 506-14, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27440100
15.
Lead-time models should not be used to estimate overdiagnosis in cancer screening.
J Gen Intern Med;
29(9): 1283-6, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24590736
16.
Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia.
Cochrane Database Syst Rev;
(9): CD000969, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25188673
17.
Routine versus selective antifungal administration for control of fungal infections in patients with cancer.
Cochrane Database Syst Rev;
(9): CD000026, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25188768
18.
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Cochrane Database Syst Rev;
(9): CD002033, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25188770
19.
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Cochrane Database Syst Rev;
(9): CD000239, 2014 Sep 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25188769
20.
Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia.
Cochrane Database Syst Rev;
(2): CD004707, 2014 Feb 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24563222